Psychiatric Symptoms in Amyotrophic Lateral Sclerosis: Beyond a Motor Neuron Disorder

The historical view that Amyotrophic Lateral Sclerosis (ALS) as a pure motor disorder has been increasingly challenged by the discovery of cognitive and behavioral changes in the spectrum of Frontotemporal Dementia (FTD). Less recognized and still significant comorbidities that ALS patients may pres...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in neuroscience Vol. 13; p. 175
Main Authors Zucchi, Elisabetta, Ticozzi, Nicola, Mandrioli, Jessica
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Research Foundation 11.03.2019
Frontiers Media S.A
Subjects
Online AccessGet full text
ISSN1662-453X
1662-4548
1662-453X
DOI10.3389/fnins.2019.00175

Cover

More Information
Summary:The historical view that Amyotrophic Lateral Sclerosis (ALS) as a pure motor disorder has been increasingly challenged by the discovery of cognitive and behavioral changes in the spectrum of Frontotemporal Dementia (FTD). Less recognized and still significant comorbidities that ALS patients may present are prior or concomitant psychiatric illness, such as psychosis and schizophrenia, or mood disorders. These non-motor symptoms disturbances have a close time relationship with disease onset, may constitute part of a larger framework of network disruption in motor neuron disorders, and may impact ALS patients and families, with regards to ethical choices and end-of-life decisions. This review aims at identifying the most common psychiatric alterations related to ALS and its prognosis, looking at a common genetic background and shared structural brain pathology.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
Edited by: Foteini Christidi, National and Kapodistrian University of Athens Medical School, Greece
This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience
Reviewed by: Giorgia Querin, INSERM U1146 Laboratoire d’Imagerie Biomédicale, France; Panagiotis Ferentinos, National and Kapodistrian University of Athens, Greece
ISSN:1662-453X
1662-4548
1662-453X
DOI:10.3389/fnins.2019.00175